Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...

Gilead’s daily antiviral pills can prevent HIV transmission and slow AIDS. While an HIV vaccine remains the Holy Grail, Gilead’s new long-lasting injection, lenacapavir, is the next best thing.

Gilead Sciences and Kymera Therapeutics have entered into a partnership worth as much as $750m to develop a molecular glue degrader (MGD) programme with “broad oncology treatment potential”. The ...

By Colin Kellaher Gilead Sciences and Kymera Therapeutics have inked an exclusive cancer-drug option and licensing agreement potentially worth hundreds of million of dollars to Kymera.

The five ‘Stans’, independent nations since 1991, are influenced by their neighbours, but distinctive and fascinating.

Gilead Sciences has made yet another rush into the oncology category, licensing a bispecific antibody from MacroGenics in development as a treatment for CD123-positive blood cancers, including ...

Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there are concerns about accessiblity.

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously ...

The Investment Committee give you their top stocks to watch for the second half.

Review quarterly and annual revenue, net income, and cash flow for Gilead Sciences Inc (GILD:XNAS) stock through the last fiscal year.

(Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including HIV-preventing ...

Gilead opens to move ahead with additional development in both its Vintage Park and Chess Hatch properties in Foster City.